Flotetuzumab for the Treatment of Pediatric Recurrent or Refractory Acute Myeloid Leukemia
Clinical trial NCT04158739 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04158739
- Sponsor
- Children's Oncology Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-22
- Primary completion
- 2022-09-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.